Human Genome Sciences (HGSI)
$27.06
1.30 (+5.05%)
| CAPS Rating |
|
|---|---|
| Open | $26.12 |
| Previous Close | $25.76 |
| Daily Range | $26.06 - $27.19 |
| 52-Week Range | $0.45 - $32.07 |
| Market Cap | $4.47B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 4,094,622 |
| Average Daily Volume | 0 |
How do you think HGSI will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
HGSI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
HGSI News and Commentary
- UK court rules HGS gene patent invalid -lawyers – Reuters
- Glaxo Brings Home the Bacon – The Motley Fool
- The Answer You've Been Waiting For – The Motley Fool
- Cashing In on Obamacare – The Motley Fool
- Whatever Happened to That Sucker's Rally? – The Motley Fool
- The Wrong Thing to Do With Your Money – The Motley Fool
- Danger! Horror! Get Out! – The Motley Fool
- Drug Companies Likely To Stay Cautious On Large Biotech Deals – SmartMoney
- $1,000 Genomes, Here We Come – The Motley Fool
- Human Genome Working To Ensure Supply Of Lupus Drug – SmartMoney
- Swine Flu: The Side Dish That Couldn't Last – The Motley Fool
- How Games Can Make You a Better Investor – The Motley Fool
- 7 Stocks That Could Cause Permanent Losses – The Motley Fool
- Two Fake "Insights" That Will Sink Your Portfolio – The Motley Fool
- 4 Ways to Retire Well – The Motley Fool
- 9 Stocks That Shook the Market in 2009 – The Motley Fool
- How to Save Your Retirement – The Motley Fool
- Rocket Stock or Dud? – The Motley Fool
- 2009 Biotech Cheers and Jeers – The Motley Fool
- 3 Stocks to Battle a Double-Dip Recession – The Motley Fool


RSS Headlines
Fool UK